ENZC — Enzolytics Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $5.74m
- $5.95m
Annual income statement for Enzolytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 July 31st | 2009 December 31st | R2010 December 31st | 2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10-K | ARS | ARS | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.015 | 0.037 | 0.053 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.064 | 0.95 | 4.26 | 0.639 | 0.938 |
| Operating Profit | -0.064 | -0.935 | -4.22 | -0.586 | -0.938 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.064 | -0.97 | -5.37 | -0.883 | -0.965 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.064 | -0.97 | -5.37 | -0.883 | -0.965 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.064 | -0.97 | -5.37 | -0.883 | -0.965 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.063 | -0.97 | -5.37 | -0.883 | -0.965 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -239 | -257 | -292 | -12.6 | -0.676 |
| Dividends per Share |